Next Article in Journal
Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
Next Article in Special Issue
Mixing Acid Salts and Layered Double Hydroxides in Nanoscale under Solid Condition
Previous Article in Journal
Development of Multilayer Microcapsules by a Phase Coacervation Method Based on Ionic Interactions for Textile Applications
Previous Article in Special Issue
Influence of Hydrothermal Treatment on Physicochemical Properties and Drug Release of Anti-Inflammatory Drugs of Intercalated Layered Double Hydroxide Nanoparticles
Pharmaceutics 2014, 6(2), 298-332; doi:10.3390/pharmaceutics6020298
Review

Layered Double Hydroxide-Based Nanocarriers for Drug Delivery

, *  and
Received: 11 April 2014; in revised form: 15 May 2014 / Accepted: 20 May 2014 / Published: 17 June 2014
(This article belongs to the Special Issue Layered Double Hydroxide Used in Drug Delivery)
Abstract: Biocompatible clay materials have attracted particular attention as the efficient drug delivery systems (DDS). In this article, we review developments in the use of layered double hydroxides (LDHs) for controlled drug release and delivery. We show how advances in the ability to synthesize intercalated structures have a significant influence on the development of new applications of these materials. We also show how modification and/or functionalization can lead to new biotechnological and biomedical applications. This review highlights the most recent progresses in research on LDH-based controlled drug delivery systems, focusing mainly on: (i) DDS with cardiovascular drugs as guests; (ii) DDS with anti-inflammatory drugs as guests; and (iii) DDS with anti-cancer drugs as guests. Finally, future prospects for LDH-based drug carriers are also discussed.
Keywords: layered double hydroxides; drug delivery system; controlled release; intercalation assembly; cardiovascular drug; anti-inflammatory drug; anti-cancer drug layered double hydroxides; drug delivery system; controlled release; intercalation assembly; cardiovascular drug; anti-inflammatory drug; anti-cancer drug
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bi, X.; Zhang, H.; Dou, L. Layered Double Hydroxide-Based Nanocarriers for Drug Delivery. Pharmaceutics 2014, 6, 298-332.

AMA Style

Bi X, Zhang H, Dou L. Layered Double Hydroxide-Based Nanocarriers for Drug Delivery. Pharmaceutics. 2014; 6(2):298-332.

Chicago/Turabian Style

Bi, Xue; Zhang, Hui; Dou, Liguang. 2014. "Layered Double Hydroxide-Based Nanocarriers for Drug Delivery." Pharmaceutics 6, no. 2: 298-332.


Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert